Search Within

Cassandra Beatrice Chang

Formats
  1. Meeting Abstract (15)
  2. Journal Article (3)
Groups
  1. Breast Medicine Service (17)
  2. Department of Medicine (17)
  3. Solid Tumor Oncology Division (17)
  4. Survivorship Research (17)
  5. Population Sciences Research Program (14)
  6. Epidemiology and Biostatistics (13)

More Groups

People
  1. Shari Goldfarb (9)
  2. Nadia Abdo (8)
  3. Yuan Chen (7)
  4. Andrea Carpio (5)
  5. Neil Iyengar (5)
  6. Sherry Shen (5)

More People

Years
  1. 2025 (1)
  2. 2024 (3)
  3. 2023 (4)
  4. 2022 (5)
  5. 2020 (1)
  6. 2018 (1)

More Years

Publications
  1. Journal of Clinical Oncology (10)
  2. Journal of Sexual Medicine (2)
  3. Cancer (1)
  4. Cancer Research (1)
  5. Clinical Breast Cancer (1)
  6. Journal of Cancer Survivorship (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (10)
  2. Elsevier Inc. (3)
  3. American Association for Cancer Research (1)
  4. Elsevier Science, Inc. (1)
  5. John Wiley & Sons (1)
  6. Springer (1)

More Publishers

Results (18)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Fertility preservation decisions and outcomes of young women with breast cancer
    Meeting Abstract

    Isseroff, D.; Thom, B.; Chang, C.; Abdo, N.; Semler, R.; Gemignani, M.; Kelvin, J. F.; Goldfarb, S. B.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Flibanserin improves libido in women with breast cancer
    Meeting Abstract

    Goldfarb, S.; Carter, J.; Arkema, A.; Abdo, N.; Carpio, A.; Chang, C.; Vahdat, L.
    Journal of Sexual Medicine (2022)

    Fulltext@MSK | Save
  • Oncofertility decision making in breast cancer patients
    Meeting Abstract

    Thom, B.; Benedict, C.; Abdo, N.; Casson, A.; Chang, C.; Gemignani, M. L.; Hershberger, P.; Kelvin, J. F.; Martino, L.; Semler, R.; more...
    Psycho-Oncology (2022)

    Fulltext@MSK | Save
  • Family building preferences among young women with invasive breast cancer
    Meeting Abstract

    Crown, A.; Abdo, N.; Noy, A.; Chang, C.; Gemignani, M.; Goldfarb, S. B.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Phase 2 study of dose-dense doxorubicin and cyclophosphamide followed by eribulin mesylate with or without prophylactic growth factor for adjuvant treatment of early-stage human epidermal growth factor receptor 2–negative breast cancer
    Journal Article

    Cadoo, K. A.; Kaufman, P. A.; Seidman, A. D.; Chang, C.; Xing, D.; Traina, T. A.
    Clinical Breast Cancer (2018)

    Fulltext@MSK | Save
  • Phase 2 study of dose-dense doxorubicin and cyclophosphamide followed by eribulin mesylate with or without prophylactic growth factor for adjuvant treatment of early-stage breast cancer
    Meeting Abstract

    Cadoo, K.; Kaufman, P. A.; Hudis, C.; Chang, C.; Berrak, E.; Song, J.; Seidman, A. D.; Traina, T. A.
    Cancer Research (2016)

    Fulltext@MSK | Save
  • Phase 2 feasibility study of dose-dense doxorubicin and cyclophosphamide (AC) followed by eribulin mesylate with or without prophylactic growth factor (GF) for adjuvant treatment of early-stage breast cancer (EBC)
    Meeting Abstract

    Traina, T. A.; Kaufman, P. A.; Cadoo, K. A.; Hudis, C. A.; Chang, C.; Berrak, E.; Song, J.; Cox, D.; Seidman, A. D.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Sequential utilization of two distinct VDR coactivator complexes, Mediator/DRIP and p160/SRC, during keratinocyte differentiation
    Meeting Abstract

    Oda, Y.; Sihlbom, C.; Huang, L.; Rachez, C.; Chang, C. B.; Burlingame, A. L.; Freedman, L. P.; Bikle, D. D.
    Journal of Investigative Dermatology (2002)

    Fulltext@MSK | Save